1. Home
  2. UPC vs CVKD Comparison

UPC vs CVKD Comparison

Compare UPC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • CVKD
  • Stock Information
  • Founded
  • UPC 1998
  • CVKD 2022
  • Country
  • UPC China
  • CVKD United States
  • Employees
  • UPC N/A
  • CVKD N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • UPC Health Care
  • CVKD Health Care
  • Exchange
  • UPC Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • UPC 2.2M
  • CVKD 29.5M
  • IPO Year
  • UPC 2021
  • CVKD 2023
  • Fundamental
  • Price
  • UPC $3.87
  • CVKD $12.80
  • Analyst Decision
  • UPC
  • CVKD Strong Buy
  • Analyst Count
  • UPC 0
  • CVKD 1
  • Target Price
  • UPC N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • UPC 28.8K
  • CVKD 32.3K
  • Earning Date
  • UPC 07-11-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • UPC N/A
  • CVKD N/A
  • EPS Growth
  • UPC N/A
  • CVKD N/A
  • EPS
  • UPC N/A
  • CVKD N/A
  • Revenue
  • UPC $19,293,003.00
  • CVKD N/A
  • Revenue This Year
  • UPC N/A
  • CVKD N/A
  • Revenue Next Year
  • UPC N/A
  • CVKD N/A
  • P/E Ratio
  • UPC N/A
  • CVKD N/A
  • Revenue Growth
  • UPC N/A
  • CVKD N/A
  • 52 Week Low
  • UPC $2.51
  • CVKD $5.70
  • 52 Week High
  • UPC $2,592.00
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • UPC 40.71
  • CVKD 49.60
  • Support Level
  • UPC $3.55
  • CVKD $11.00
  • Resistance Level
  • UPC $3.91
  • CVKD $13.71
  • Average True Range (ATR)
  • UPC 0.21
  • CVKD 1.14
  • MACD
  • UPC 0.01
  • CVKD 0.10
  • Stochastic Oscillator
  • UPC 38.48
  • CVKD 63.54

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: